DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/3f5696/dermalogica_inc) has announced the addition of iCD Research's new company profile "Dermalogica, Inc.: Company Profile and SWOT Analysis" to their offering.
Dermalogica, Inc. (Dermalogica) is a cosmetics company. It engages in manufacturing and selling skin care products. Dermalogica serves consumers and skin care professionals through skin treatment centers, salons and spas in the US and internationally. The company's product portfolio comprises moisturizers, shampoos, toners, cleansers, exfoliants and conditioners. Its products system also includes UltraCalming, skin health, AGE smart, body therapy, daylight defense, shave, mediBac clearing and ChromaWhite TRx. These products are offered through over 75,000 qualified skin care professionals in 48 countries worldwide. The company has principal operations in the US, the UK, Australia, Ireland, and Canada. Dermalogica is headquartered in Carson, California, the US.
ICD Research's "Dermalogica, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Increase business/sales activities by understanding your competitors' businesses better
- Recognize potential partnerships and suppliers
For more information visit http://www.researchandmarkets.com/research/3f5696/dermalogica_inc